Impulse News

Randomization of the FIX-HF-5C Confirmatory Study Completed

Orangeburg, New York, March 31, 2017 — Impulse Dynamics is pleased to announce that it has successfully completed enrollment of the 160 subjects required for its FIX-HF-5C Confirmatory Study. The FIX-HF-5C Study is a prospective, multicenter, randomized study to evaluate the safety and efficacy of cardiac contractility modulation (CCM) signals delivered by the implantable Optimizer […]

Read more

Going red to raise awareness of heart disease in women

Mt. Laurel, New Jersey, February 3 2017 Friday February 3rd saw women and men across the United States dressed in shades of red, from scarlet to crimson, for National Wear Red Day. February has been known as American Heart Month since the early 1960s, but in 2003 National Wear Red Day was introduced specifically to […]

Read more

CCM device makes a positive difference in life of chronic heart failure patient

Stuttgart – Diagnosed with chronic heart failure in 2009, Jürgen Schuller experienced recurrent hospital admissions and symptoms which seriously impaired his quality of life. Treatment via medication and an implantable cardioverter/defibrillator (ICD), although life-saving for many heart disease patients, failed to improve his condition. However, since receiving Impulse Dynamics’ OPTIMIZER device, Mr. Schuller has experienced […]

Read more

Impulse Dynamics Successfully Launches the Optimizer Smart Device for Heart Failure Treatment in Europe

Impulse Dynamics has launched the next generation of its Optimizer device, the Optimizer Smart, in Europe after it received the CE mark. The Optimizer Smart is a minimally invasive implantable device designed to treat chronic heart failure (CHF) in patients that are symptomatic despite appropriate medical therapy. The device is based on novel cardiac contractility […]

Read more

Impulse Dynamics Recognized with Frost & Sullivan’s 2016 New Product Innovation Award

September 12, 2016 – Impulse Dynamics, developer of the Optimizer™ IVs implantable device for the treatment of Chronic Heart Failure (CHF), is the recipient of the prestigious Frost & Sullivan 2016 European Chronic Heart Failure Therapy New Product Innovation Award. Based on a recent analysis of the European chronic heart failure therapy market, Frost & […]

Read more

CCM Therapy presented by Charité Berlin at the 2016 Heart Failure Annual Meeting

Stuttgart, 6th June 2016 – An international audience of professionals at HFA 2016 – Heart Failure Annual Meeting was updated by the Charité Universitätsmedizin Berlin on the latest Clinical data for Cardiac Contractility Modulation (CCM) Therapy delivered by the Optimizer device. Heart Failure is the annual congress of the European Society of Cardiology’s Heart Failure […]

Read more

CCM Therapy in ESC Guidelines for Diagnosis and Treatment of CHF

Stuttgart– May 22, 2016 – Cardiac Contractility Modulation (CCM) Therapy delivered by the Optimizer System has, for the first time, been included in the European Society of Cardiology’s (ESC) 2016 guidelines for the diagnosis and treatment of acute and chronic heart failure (http://www.escardio.org/Guidelines-&-Education/Clinical-Practice-Guidelines/Acute-and-Chronic-Heart-Failure) released last week. CCM Therapy is based on non-excitatory electric pulses that […]

Read more

Impulse Dynamics Completes $30 Million Financing Round

Mt. Laurel, New Jersey, May 13 2016 – Impulse Dynamics, developer of the Optimizer™ IVs implantable device for treatment of chronic heart failure (CHF), announced today that the company has closed a $30 million financing round. The equity financing round was led by the investment fund of Dr. Peter Lee Ka Kit, Vice Chairman of […]

Read more

Continued growth within Europe – Impulse Dynamics announces the first implantations of the Optimizer IVs device in the Slovenia.

Stuttgart, Germany, March 2016 Impulse Dynamics announced the first two implantations of its Optimizer IVs device in Slovenia. The Optimizer IVs is a minimally invasive implantable device designed to treat Chronic Heart Failure (CHF). The device is based on the innovative Cardiac Contractility Modulation (CCM) technology, which delivers non-excitatory electric pulses to the heart. The […]

Read more
Page 1 of 512345